Evidence map›Paper›PMID 34163158›Full record

ArticleInternational journal of nanomedicine2021

Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes.

Matteo Petrini, Wouter J M Lokerse, Agnieszka Mach, Martin Hossann, Olivia M Merkel, Lars H Lindner

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Smart stimuli-responsive drug delivery systems in spotlight of COVID-19.Asian journal of pharmaceutical sciences · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Charge reversal nano-systems for tumor therapy.Journal of nanobiotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Matteo PetriniDepartment of Internal Medicine III, University Hospital, Ludwig Maximilian University, Munich, Germany.ORCID 0000-0002-2345-8327
Wouter J M LokerseDepartment of Internal Medicine III, University Hospital, Ludwig Maximilian University, Munich, Germany.ORCID 0000-0001-7083-1975
Agnieszka MachDepartment of Internal Medicine III, University Hospital, Ludwig Maximilian University, Munich, Germany.ORCID 0000-0003-0076-867X
Martin HossannThermosome GmbH, Planegg, Germany.ORCID 0000-0002-7592-5919
Olivia M MerkelDepartment of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig Maximilian University, Munich, Germany.ORCID 0000-0002-4151-3916
Lars H LindnerDepartment of Internal Medicine III, University Hospital, Ludwig Maximilian University, Munich, Germany.ORCID 0000-0003-3708-8264
Ludwig-Maximilians-Universität München · DEUrologische Klinik München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePrevious studies demonstrated the possibility of targeting tumor-angiogenic endothelial cells with positively charged nanocarriers, such as cationic liposomes. We investigated the active targeting potential of positively charged nanoparticles in combination with the heat-induced drug release function of thermosensitive liposomes (TSL). This novel dual-targeted approach via cationic TSL (CTSL) was thoroughly explored using either a novel synthetic phospholipid 1,2-dipalmitoyl- MATERIALS AND

methodsDPPG

resultsThe absence of PEG in PG

conclusionCationic particles showed lower hemocompatibility than their anionic counterparts, which was partially mitigated when PEG was grafted on the liposome surface. DPPG

Indexed as

Cell CommunicationDrug Delivery SystemsTemperatureAnimalsCell Line, TumorDoxorubicinDrug LiberationHumansHuman Umbilical Vein Endothelial CellsInhibitory Concentration 50Intracellular SpaceLiposomesNeoplasmsPhosphatidylglycerolsPolyethylene GlycolsRats1,2-dipalmitoylphosphatidylglycerolDoxorubicinLiposomesPhosphatidylglycerolsPolyethylene Glycolscationic liposomesdrug deliverydual tumor targetingliposome functionalizationmild hyperthermiathermosensitive liposomes

Identifiers

PMID34163158
PMCPMC8214027
OpenAlexW3166959588

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.